Click here to access the full blog
- A new NHSGGC guideline has been published on the Right Decision Platform: Management plan for patients on warfarin and direct oral anticoagulants (DOACs) in the peri-operative period.
- The new NHSGGC guideline includes:
- Updated recommendations on thrombosis risk categories for elective procedures.
- A clear presentation of different DOACs and the time frame between the last dose and high bleeding risk procedures.
- Updated recommendations on low molecular weight heparin (LMWH) dose in the peri-operative period.
- Updated CHADS-VA score in line with new recommendations from the European Society of Cardiology.